Serotonin toxicity precipitated by concomitant use of citalopram and methylene blue

Medical Journal of Australia

Volumn 189, Issue 9, 2008, Pages 534-535

  Khavandi, Ali ^a   Whitaker, John ^a   Gonna, Hanney ^a  

^a SOUTHMEAD HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ALFENTANIL; ATENOLOL; BENDROFLUMETHIAZIDE; CITALOPRAM; DEXAMETHASONE; FELODIPINE; ISOSORBIDE MONONITRATE; METHYLENE BLUE; MORPHINE; PROPOFOL; REMIFENTANIL; ROCURONIUM; SEROTONIN; SIMVASTATIN;

ADULT; AGITATION; ANALGESIA; ANAMNESIS; CASE REPORT; DEPRESSION; DOSE RESPONSE; DRUG WITHDRAWAL; EVENING DOSAGE; FEMALE; GENERAL ANESTHESIA; HUMAN; HYPERPARATHYROIDISM; HYPERTENSION; INTENSIVE CARE UNIT; ISCHEMIC HEART DISEASE; LETTER; MYDRIASIS; MYOCLONUS; NEUROLOGIC EXAMINATION; OBESITY; PARATHYROIDECTOMY; POSTOPERATIVE PERIOD; PREOPERATIVE CARE; RESTLESSNESS; SEROTONIN SYNDROME; UNSPECIFIED SIDE EFFECT;

EID: 56749083655     PISSN: 0025729X     EISSN: None     Source Type: Journal    
DOI: 10.5694/j.1326-5377.2008.tb02168.x     Document Type: Letter

References (3)

1. Boyer EW, Shannon M. The serotonin syndrome. N Engl J Med 2005; 352: 1112-1120.
2. Ramsay RR, Dunford C, Gillman PK. Methylene blue and serotonin toxicity: inhibition of monoamine oxidase A (MAO A) confirms a theoretical prediction. Br J Pharmacol 2007; 152: 946-951.
3. Kartha SS, Chacko CE, Bumpous JM, et al. Toxic metabolic encephaolopathy after parathyroidectomy with methylene blue localization. Otolaryngol Head Neck Surg 2006; 135: 765-768.